Pathstone Holdings, LLC Incyte Corp Transaction History
Pathstone Holdings, LLC
- $25.3 Billion
- Q2 2025
A detailed history of Pathstone Holdings, LLC transactions in Incyte Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 9,937 shares of INCY stock, worth $854,184. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,937
Previous 9,915
0.22%
Holding current value
$854,184
Previous $600,000
12.67%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding INCY
# of Institutions
736Shares Held
202MCall Options Held
516KPut Options Held
265K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.64 Billion21.22% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.84 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.1MShares$1.73 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.6MShares$1.25 Billion0.6% of portfolio
-
State Street Corp Boston, MA9.88MShares$849 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $19.1B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...